[Peripheral Arterial Disease: When is a PCSK9 Inhibitor Useful?].

Kröger K, Espinola-Klein C, Hoffmann U, Kalka C, Lawall H, Weiss N

Open source

DOI
10.1055/a-0639-8325
Published
2018 Sep
Container
Deutsche medizinische Wochenschrift (1946)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-0639-8325,
  title = {[Peripheral Arterial Disease: When is a PCSK9 Inhibitor Useful?].},
  author = {Kröger K and Espinola-Klein C and Hoffmann U and Kalka C and Lawall H and Weiss N},
  year = {2018},
  journal = {Deutsche medizinische Wochenschrift (1946)},
  doi = {10.1055/a-0639-8325},
  url = {https://doi.org/10.1055/a-0639-8325}
}

RIS

TY  - JOUR
TI  - [Peripheral Arterial Disease: When is a PCSK9 Inhibitor Useful?].
AU  - Kröger K
AU  - Espinola-Klein C
AU  - Hoffmann U
AU  - Kalka C
AU  - Lawall H
AU  - Weiss N
PY  - 2018
JO  - Deutsche medizinische Wochenschrift (1946)
DO  - 10.1055/a-0639-8325
UR  - https://doi.org/10.1055/a-0639-8325
ER  - 

APA

K, K., C, E., U, H., C, K., H, L., & N, W. (2018). [Peripheral Arterial Disease: When is a PCSK9 Inhibitor Useful?].. Deutsche medizinische Wochenschrift (1946). https://doi.org/10.1055/a-0639-8325

Source records